Clinical Research Directory
Browse clinical research sites, groups, and studies.
Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma
Sponsor: Ain Shams University
Summary
Saffron has recently gained considerable interest for its capacity to interfere with cancer at initiation and promotion stages as well as for cancer treatment. Although saffron and its constituents have been shown to have antitumorigenic and proapoptotic activities in different cancer cell lines. The aim of the current investigation is to identify the anti-cancer potentiality of saffron on hepatocellular carcinoma patients.
Official title: Anti Cancer Potential of Saffron in Hepatocellular Carcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-10-30
Completion Date
2025-10-01
Last Updated
2024-09-23
Healthy Volunteers
No
Conditions
Interventions
Saffranal
HCC patients will receive 50 mg safranal regimen in dose of once per day for six months.
Placebo
HCC patients will receive Placebo in dose of once per day for six months.
Locations (2)
Amal A. Elkholy
Al ‘Abbāsīyah, Al Abbasiya, Egypt
Dermatology Clinic of National Hepatology and Tropical Medicine Research Institute
Cairo, Egypt